107 related articles for article (PubMed ID: 12090737)
1. Chemosensitization of solid tumor cells by alteration of their susceptibility to apoptosis.
Cree IA; Knight L; Di Nicolantonio F; Sharma S; Gulliford T
Curr Opin Investig Drugs; 2002 Apr; 3(4):641-7. PubMed ID: 12090737
[TBL] [Abstract][Full Text] [Related]
2. Chemosensitization of solid tumors by modulation of resistance mechanisms.
Cree IA; Knight L; Di Nicolantonio F; Sharma S; Gulliford T
Curr Opin Investig Drugs; 2002 Apr; 3(4):634-40. PubMed ID: 12090736
[TBL] [Abstract][Full Text] [Related]
3. Impact of multicellular resistance on the survival of solid tumors, including micrometastases.
Kerbel RS
Invasion Metastasis; 1994-1995; 14(1-6):50-60. PubMed ID: 7657532
[TBL] [Abstract][Full Text] [Related]
4. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
Kostanová-Poliaková D; Sabová L
Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
[TBL] [Abstract][Full Text] [Related]
5. Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors.
Tatsumi N; Oji Y; Tsuji N; Tsuda A; Higashio M; Aoyagi S; Fukuda I; Ito K; Nakamura J; Takashima S; Kitamura Y; Miyai S; Jomgeow T; Li Z; Shirakata T; Nishida S; Tsuboi A; Oka Y; Sugiyama H
Int J Oncol; 2008 Mar; 32(3):701-11. PubMed ID: 18292948
[TBL] [Abstract][Full Text] [Related]
6. Harnessing apoptosis for improved anticancer gene therapy.
Waxman DJ; Schwartz PS
Cancer Res; 2003 Dec; 63(24):8563-72. PubMed ID: 14695163
[TBL] [Abstract][Full Text] [Related]
7. Selective anticancer strategies via intervention of the death pathways relevant to cell transformation.
Li QX; Yu DH; Liu G; Ke N; McKelvy J; Wong-Staal F
Cell Death Differ; 2008 Aug; 15(8):1197-210. PubMed ID: 18437165
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cell death in the tumor microenvironment.
Wouters BG; Koritzinsky M; Chiu RK; Theys J; Buijsen J; Lambin P
Semin Radiat Oncol; 2003 Jan; 13(1):31-41. PubMed ID: 12520462
[TBL] [Abstract][Full Text] [Related]
9. A role for intracellular immunization in chemosensitization of tumor cells?
Pich A; Rancourt C
Gene Ther; 1999 Jul; 6(7):1202-9. PubMed ID: 10455428
[TBL] [Abstract][Full Text] [Related]
10. Targeting death-inducing receptors in cancer therapy.
Takeda K; Stagg J; Yagita H; Okumura K; Smyth MJ
Oncogene; 2007 May; 26(25):3745-57. PubMed ID: 17530027
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
12. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
[TBL] [Abstract][Full Text] [Related]
13. Implications of apoptotic cell death regulation in cancer therapy.
McDonnell TJ; Meyn RE; Robertson LE
Semin Cancer Biol; 1995 Feb; 6(1):53-60. PubMed ID: 7548842
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
15. Prospective strategies to enforce selectively cell death in cancer cells.
Blagosklonny MV
Oncogene; 2004 Apr; 23(16):2967-75. PubMed ID: 15077157
[TBL] [Abstract][Full Text] [Related]
16. Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia.
Cao X; Fang L; Gibbs S; Huang Y; Dai Z; Wen P; Zheng X; Sadee W; Sun D
Cancer Chemother Pharmacol; 2007 Mar; 59(4):495-505. PubMed ID: 16906425
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic gene therapy for cancer (review).
Isayeva T; Kumar S; Ponnazhagan S
Int J Oncol; 2004 Aug; 25(2):335-43. PubMed ID: 15254730
[TBL] [Abstract][Full Text] [Related]
18. Signaling through death receptors in cancer therapy.
Fulda S; Debatin KM
Curr Opin Pharmacol; 2004 Aug; 4(4):327-32. PubMed ID: 15251124
[TBL] [Abstract][Full Text] [Related]
19. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
Ng CP; Zisman A; Bonavida B
Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
[TBL] [Abstract][Full Text] [Related]
20. SV40 T/t-common polypeptide specifically induces apoptosis in human cancer cells that overexpress HER2/neu.
Wen CC; Cheng SA; Hsuen SP; Huang YL; Kuo ZK; Lee HF; Kuo CH; Du JL; Wang WB
Cancer Res; 2006 Jun; 66(11):5847-57. PubMed ID: 16740724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
